The ability to detect single protein molecules 1 , 2 in blood could accelerate the discovery
and use of more sensitive diagnostic biomarkers. To detect low-abundance proteins in blood, …

… The authors declare the following competing financial interest(s): David R. Walt is
scientific founder, director, and an equity holder of Quanterix Corporation. The company is …

Despite decades of accumulated knowledge about proteins and their post-translational
modifications (PTMs), numerous questions remain regarding their molecular composition and …

Conventional approaches to chemical sensors have traditionally made use of a “lock-and-key”
design, wherein a specific receptor is synthesized in order to strongly and highly …

Rapid, accurate and frequent detection of the RNA of SARS-CoV-2 (severe acute respiratory
syndrome coronavirus 2) and of serological host antibodies to the virus would facilitate the …

DNA microarrays have revolutionized the collection and analysis of genetic information. The
monitoring of RNA expression and DNA variations has contributed dramatically to our …

… The authors declare the following competing financial interest(s): David R. Walt is the
scientific founder and a board member of Quanterix Corporation. All other authors declare no …

Rapid progress in identifying disease biomarkers has increased the importance of creating
high-performance detection technologies. Over the last decade, the design of many detection …

A more complete understanding of the causes and effects of cell-cell variability in gene
expression is needed to elucidate whether the resulting phenotypes are disadvantageous or …

Multisystem inflammatory syndrome in children (MIS-C) occurs during or recently following
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and is …